The core activity of HBM Partners is investing in and managing healthcare companies, particularly in the areas of biopharma, medtech, diagnostics and healthcare in Europe and North America. The company invests in private and public companies and supports their growth through all stages of development, focusing on creating value through the use of its experience and global network. HBM Partners manages assets of $2.1 billion and typically invests between $5 million and $50 million in companies.